| Name | IDO-IN-4 |
|---|---|
| Synonyms |
Cyclopropanecarboxylic acid, 2-[4-[bis(2-methylpropyl)amino]-3-[[[(4-methylphenyl)amino]carbonyl]amino]phenyl]-, (1R,2S)-
(1R,2S)-2-[4-(Diisobutylamino)-3-{[(4-methylphenyl)carbamoyl]amino}phenyl]cyclopropanecarboxylic acid |
| Description | IDO-IN-4 is an indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, extracted from patent WO2014150677A1, Compound example 1 enantiomer 1. |
|---|---|
| Related Catalog | |
| Target |
IDO-1 |
| In Vitro | IDO-IN-4 (Compound example 1 enantiomer 1) is a IDO-1 inhibitor in human IDO1/HEK293 cells[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 532.6±50.0 °C at 760 mmHg |
| Molecular Formula | C26H35N3O3 |
| Molecular Weight | 437.574 |
| Flash Point | 275.9±30.1 °C |
| Exact Mass | 437.267853 |
| LogP | 5.74 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.633 |
| Storage condition | 2-8℃ |